Molecular Imaging of Antiangiogenic Agents

Molecular Imaging of Antiangiogenic Agents Shazza Rehman and Gordon C. Jayson Oncologist 2005; 10: 92-103 Author Information and Disclosures Target Audience: Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Explain the rationale for targeting angiogenesis and for combining antiangiogenic agents with other chemotherapeutic agents. Name the various techniques that are available for the assessment of the antiangiogenic activity of drugs and their current limitations. Identify the role of DCE-MRI in imaging antiangiogenics. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Feb. 11, 2005 Most Recent Review: Feb. 11, 2005* Most Recent Update: Feb. 11, 2005 Date Credit Expires: Feb. 11, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.